Ob/Gyn Medical News about Aralia

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
RACs In Full Gear

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

The Depressing Thing About Cancer

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Anti-inflammatory activity of the constituents of the roots of Aralia continentalis
Archives of Pharmacal Research, 10/14/09

Kim HP et al. – The results of the study suggest that some constituents of A. continentalis, especially compounds I, III and V, exert significant anti–inflammatory activity, which suggests that these constituents contribute, at least in part, to the anti–inflammatory action of the roots of A. continentalis.

<< Previous
Update on Age at Menarche in Italy: Toward the Leveling Off of...

Next >>
The Role of Nitric Oxide Synthase Inhibition by Asymmetric...